To specifically examine the role of these PD-L1+ sEVs without the interference of PD-L1+ sEV originating from the allografts, we first generated B16F10 tumor cells with their endogenous PD-L1 knocked out (“PD-L1-KO B16F10”). This evidence concerns the gene CD274 and neoplasm.